Neuland Laboratories Limited
NEULANDLAB
LTP
N/A
Latest Quarter Update
Strong Growth Signals Future Potential 21.7% revenue increase in Q1FY25
Total Income
up 21.7% YoY
Rs. 444.4 crores
Invested Rs. 59.1 crores in capital spends
Achieved gross margin of 66.1%
Repayment of Rs. 8.7 crores in debt
Earning Calls History
Q1 FY2025 - July 12, 2024
Latest
Neuland Laboratories Limited demonstrated robust growth in Q1FY25, primarily driven by the CMS segment. The management remains optimistic about future growth while focusing on strategic investments.